Reflexion Medical, Inc.
RefleXion Medical is dedicated to revolutionizing cancer care through innovative radiotherapy technology. Their mission is to create a machine that combines biotargeting with radiation, enabling systemic reach for radiotherapy for patients at any stage of cancer. They develop and commercialize the SCINTIX biology-guided radiotherapy platform, which uses cancer's own biology to guide treatment, aiming to improve outcomes and expand treatment options for metastatic and primary cancers. The company actively engages in research, clinical adoption, and expanding applications of its breakthrough technology, including real-time PET-guided radiotherapy and adaptive treatment planning.
Industries
Nr. of Employees
medium (51-250)
Reflexion Medical, Inc.
25841 Industrial Blvd, Suite 275, Hayward, CA 94545
Patents
Products
Integrated PET/CT radiotherapy platform for emission- and image-guided treatments
A clinical radiotherapy platform that integrates onboard PET detection and a multi-slice fan-beam kVCT subsystem with a therapeutic linear accelerator to enable real-time emission-guided dose delivery, conventional IMRT/SBRT/SRS, and multi-target single-session treatments.
Integrated PET/CT radiotherapy platform for emission- and image-guided treatments
A clinical radiotherapy platform that integrates onboard PET detection and a multi-slice fan-beam kVCT subsystem with a therapeutic linear accelerator to enable real-time emission-guided dose delivery, conventional IMRT/SBRT/SRS, and multi-target single-session treatments.
Services
Funding and collaboration opportunities for investigators at accredited institutions to support independently-developed research on emission-guided radiotherapy.
Advisory services on clinical adoption workflows, billing/coding, payer engagement and site planning to support uptake in hospital outpatient and freestanding centers.
On-demand and instructor-led clinical, technical and administrative courses covering treatment planning, delivery, physics, imaging workflows, and reimbursement coding.
Partnerships with clinical sites for data collection, registry enrollment and collaborative research to generate real-world evidence and support peer-reviewed publications.
Onsite and remote support for initial beam commissioning, TPS commissioning, reference dosimetry, and establishment of daily and patient-specific QA workflows for integrated imaging-guided radiotherapy systems.
Funding and collaboration opportunities for investigators at accredited institutions to support independently-developed research on emission-guided radiotherapy.
Advisory services on clinical adoption workflows, billing/coding, payer engagement and site planning to support uptake in hospital outpatient and freestanding centers.
On-demand and instructor-led clinical, technical and administrative courses covering treatment planning, delivery, physics, imaging workflows, and reimbursement coding.
Partnerships with clinical sites for data collection, registry enrollment and collaborative research to generate real-world evidence and support peer-reviewed publications.
Onsite and remote support for initial beam commissioning, TPS commissioning, reference dosimetry, and establishment of daily and patient-specific QA workflows for integrated imaging-guided radiotherapy systems.
Expertise Areas
- Biology-guided radiotherapy and emission-guided delivery
- Image-guided radiotherapy and daily fan-beam CT imaging
- Treatment planning systems and commissioning
- Real-time motion management and tracked dose delivery
Key Technologies
- Integrated PET detection with linear-accelerator delivery (PET-guided radiotherapy)
- Multi-slice fan-beam kilovolt CT for daily imaging
- Real-time emission-based tumor tracking
- Binary multileaf collimator for high-precision beam shaping
News & Updates
RefleXion Medical announced the appointment of Steve Schoch as CFO and the promotion of Phil Aulson to COO.
Hackensack Meridian Health's John Theurer Cancer Center is among the first in the world to adopt RefleXion's X1 platform.
Susanne Kluh, a biologist diagnosed with metastatic lung cancer, was treated with SCINTIX therapy at City of Hope, which uses cancer's biology to guide targeted radiotherapy.
RefleXion was awarded the 2022 Pantheon Award for Convergent Technologies by the California Life Sciences organization.
RefleXion Medical announced the appointment of Steve Schoch as CFO and the promotion of Phil Aulson to COO.
Hackensack Meridian Health's John Theurer Cancer Center is among the first in the world to adopt RefleXion's X1 platform.
Susanne Kluh, a biologist diagnosed with metastatic lung cancer, was treated with SCINTIX therapy at City of Hope, which uses cancer's biology to guide targeted radiotherapy.
RefleXion was awarded the 2022 Pantheon Award for Convergent Technologies by the California Life Sciences organization.